<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/ClinVar_VCV_2.4.xsd" ReleaseDate="2025-06-30">
<VariationArchive RecordType="classified" VariationID="69" VariationName="NM_000374.5(UROD):c.874C&gt;G (p.Arg292Gly)" VariationType="single nucleotide variant" Accession="VCV000000069" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-09-09" MostRecentSubmission="2018-09-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15108" VariationID="69">
      <GeneList>
        <Gene Symbol="UROD" FullName="uroporphyrinogen decarboxylase" GeneID="7389" HGNC_ID="HGNC:12591" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45012254" stop="45015575" display_start="45012254" display_stop="45015575" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45477804" stop="45481340" display_start="45477804" display_stop="45481340" Strand="+"/>
          </Location>
          <OMIM>613521</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000374.5(UROD):c.874C&gt;G (p.Arg292Gly)</Name>
      <CanonicalSPDI>NC_000001.11:45014834:C:G</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45014835" stop="45014835" display_start="45014835" display_stop="45014835" variantLength="1" positionVCF="45014835" referenceAlleleVCF="C" alternateAlleleVCF="G"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45480507" stop="45480507" display_start="45480507" display_stop="45480507" variantLength="1" positionVCF="45480507" referenceAlleleVCF="C" alternateAlleleVCF="G"/>
      </Location>
      <ProteinChange>R292G</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45014835C&gt;G" Assembly="GRCh38">
            <Expression>NC_000001.11:g.45014835C&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007122.2" sequenceAccession="NG_007122" sequenceVersion="2" change="g.7678C&gt;G">
            <Expression>NG_007122.2:g.7678C&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033058.1" sequenceAccession="NG_033058" sequenceVersion="1" change="g.1521G&gt;C">
            <Expression>NG_033058.1:g.1521G&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000374.5" sequenceAccession="NM_000374" sequenceVersion="5" change="c.874C&gt;G" MANESelect="true">
            <Expression>NM_000374.5:c.874C&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000365.3" sequenceAccession="NP_000365" sequenceVersion="3" change="p.Arg292Gly">
            <Expression>NP_000365.3:p.Arg292Gly</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_036510.2" sequenceAccession="NR_036510" sequenceVersion="2" change="n.936C&gt;G">
            <Expression>NR_036510.2:n.936C&gt;G</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO"/>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_158184.1" sequenceAccession="NR_158184" sequenceVersion="1" change="n.955C&gt;G">
            <Expression>NR_158184.1:n.955C&gt;G</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO"/>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_158185.1" sequenceAccession="NR_158185" sequenceVersion="1" change="n.905C&gt;G">
            <Expression>NR_158185.1:n.905C&gt;G</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO"/>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45480507C&gt;G" Assembly="GRCh37">
            <Expression>NC_000001.10:g.45480507C&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="P06132" sequenceAccession="P06132" change="p.Arg292Gly">
            <Expression>P06132:p.Arg292Gly</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1079" sequenceAccession="LRG_1079">
            <Expression>LRG_1079:g.7678C&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1079t1" sequenceAccession="LRG_1079t1">
            <Expression>LRG_1079t1:c.874C&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1079p1" sequenceAccession="LRG_1079p1" change="p.Arg292Gly">
            <Expression>LRG_1079p1:p.Arg292Gly</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA251373" DB="ClinGen"/>
        <XRef ID="P06132#VAR_007717" DB="UniProtKB"/>
        <XRef Type="Allelic variant" ID="613521.0005" DB="OMIM"/>
        <XRef Type="rs" ID="121918059" DB="dbSNP"/>
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000374.5(UROD):c.874C&gt;G (p.Arg292Gly) AND Hepatoerythropoietic porphyria" Accession="RCV000000087" Version="4">
        <ClassifiedConditionList TraitSetID="32">
          <ClassifiedCondition DB="MedGen" ID="C0162569">Hepatoerythropoietic porphyria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-09-09" MostRecentSubmission="2018-09-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1634232</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6205" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hepatoerythropoietic porphyria</ElementValue>
                <XRef ID="320339" DB="GeneTests"/>
                <XRef ID="Hepatoerythropoietic+porphyria/3340" DB="Genetic Alliance"/>
                <XRef ID="MONDO:0019799" DB="MONDO"/>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HEP</ElementValue>
                <XRef ID="176100" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, and scarring over the affected skin areas. Disease manifestations occur during infancy or childhood and with similar frequency in females and males. Individuals with HEP are not reported to be at increased risk for hepatocellular carcinoma.</Attribute>
                <XRef ID="NBK169003" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6169"/>
                <XRef ID="6169" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24175354</ID>
                <ID Source="BookShelf">NBK169003</ID>
              </Citation>
              <XRef ID="95159" DB="Orphanet"/>
              <XRef ID="C0162569" DB="MedGen"/>
              <XRef ID="MONDO:0019799" DB="MONDO"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20230" SubmissionDate="2018-09-06" DateLastUpdated="2018-09-09" DateCreated="2013-04-04" ContributesToAggregateClassification="true">
        <ClinVarSubmissionID localKey="613521.0005_PORPHYRIA, HEPATOERYTHROPOIETIC" title="UROD, ARG292GLY_PORPHYRIA, HEPATOERYTHROPOIETIC"/>
        <ClinVarAccession Accession="SCV000020230" DateUpdated="2018-09-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Dutch sisters with hepatoerythropoietic porphyria (HEP; see 176100), de Verneuil et al. (1992) demonstrated compound heterozygosity for a deletion inherited from the father and an R292G mutation inherited from the mother.</Attribute>
              <Citation>
                <ID Source="PubMed">1634232</ID>
              </Citation>
              <XRef DB="OMIM" ID="176100" Type="MIM"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UROD"/>
          </GeneList>
          <Name>UROD, ARG292GLY</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">ARG292GLY</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613521.0005" Type="Allelic variant"/>
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PORPHYRIA, HEPATOERYTHROPOIETIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20230" TraitType="Disease" MappingType="Name" MappingValue="PORPHYRIA, HEPATOERYTHROPOIETIC" MappingRef="Preferred">
        <MedGen CUI="C0162569" Name="Hepatoerythropoietic porphyria"/>
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

<VariationArchive VariationID="722" VariationName="NM_000015.3(NAT2):c.590G&gt;A (p.Arg197Gln)" VariationType="single nucleotide variant" Accession="VCV000000722" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-11-25" DateCreated="2013-04-04" MostRecentSubmission="2024-10-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15761" VariationID="722">
      <GeneList>
        <Gene Symbol="NAT2" FullName="N-acetyltransferase 2" GeneID="10" HGNC_ID="HGNC:7646" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18386301" stop="18401218" display_start="18386301" display_stop="18401218" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="18248754" stop="18258722" display_start="18248754" display_stop="18258722" Strand="+"/>
          </Location>
          <OMIM>612182</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000015.3(NAT2):c.590G&gt;A (p.Arg197Gln)</Name>
      <CanonicalSPDI>NC_000008.11:18400592:G:A</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>8p22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18400593" stop="18400593" display_start="18400593" display_stop="18400593" variantLength="1" positionVCF="18400593" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="18258103" stop="18258103" display_start="18258103" display_stop="18258103" variantLength="1" positionVCF="18258103" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
      </Location>
      <ProteinChange>R197Q</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.18258103G&gt;A" Assembly="GRCh37">
            <Expression>NC_000008.10:g.18258103G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.18400593G&gt;A" Assembly="GRCh38">
            <Expression>NC_000008.11:g.18400593G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012246.1" sequenceAccession="NG_012246" sequenceVersion="1" change="g.14349G&gt;A">
            <Expression>NG_012246.1:g.14349G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000015.3" sequenceAccession="NM_000015" sequenceVersion="3" change="c.590G&gt;A" MANESelect="true">
            <Expression>NM_000015.3:c.590G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000006.2" sequenceAccession="NP_000006" sequenceVersion="2" change="p.Arg197Gln">
            <Expression>NP_000006.2:p.Arg197Gln</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000015.2" sequenceAccession="NM_000015" sequenceVersion="2" change="c.590G&gt;A">
            <Expression>NM_000015.2:c.590G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114447" DB="ClinGen"/>
        <XRef Type="Allelic variant" ID="612182.0001" DB="OMIM"/>
        <XRef Type="rs" ID="1799930" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.26015" Source="1000 Genomes Project 30x"/>
        <AlleleFrequency Value="0.26428" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.26498" Source="1000 Genomes Project"/>
        <AlleleFrequency Value="0.26979" Source="The Genome Aggregation Database (gnomAD)"/>
        <AlleleFrequency Value="0.27285" Source="The Genome Aggregation Database (gnomAD), exomes"/>
        <AlleleFrequency Value="0.27727" Source="Exome Aggregation Consortium (ExAC)"/>
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.26498" Source="1000 Genomes Project" MinorAllele="A"/>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000015.3(NAT2):c.590G&gt;A (p.Arg197Gln) AND Slow acetylator due to N-acetyltransferase enzyme variant" Accession="RCV000000758" Version="9">
        <ClassifiedConditionList TraitSetID="178">
          <ClassifiedCondition DB="MedGen" ID="C0878587">Slow acetylator due to N-acetyltransferase enzyme variant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-10-28" SubmissionCount="1">drug response</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000015.3(NAT2):c.590G&gt;A (p.Arg197Gln) AND NAT2-related disorder" Accession="RCV003974784" Version="2">
        <ClassifiedConditionList TraitSetID="94933">
          <ClassifiedCondition>NAT2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-03-29" SubmissionCount="1">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-10-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Benign; drug response</Description>
        <Citation Type="general">
          <ID Source="PubMed">18043717</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2068113</ID>
        </Citation>
        <DescriptionHistory Dated="2024-10-05">
          <Description>Benign</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2024-03-14">
          <Description>drug response</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="94933" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="74782" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">NAT2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NAT2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="178" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62" Type="DrugResponse">
              <Name>
                <ElementValue Type="Alternate">INH INACTIVATION, SLOW</ElementValue>
                <XRef Type="MIM" ID="243400" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ISONIAZID INACTIVATION, SLOW</ElementValue>
                <XRef Type="MIM" ID="243400" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLOW ACETYLATOR PHENOTYPE</ElementValue>
                <XRef Type="MIM" ID="243400" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetylation, slow</ElementValue>
                <XRef ID="MONDO:0009472" DB="MONDO"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Slow acetylator due to N-acetyltransferase enzyme variant</ElementValue>
                <XRef ID="Acetylation%2C+slow/7622" DB="Genetic Alliance"/>
                <XRef ID="425079005" DB="SNOMED CT"/>
              </Name>
              <XRef ID="C0878587" DB="MedGen"/>
              <XRef ID="MONDO:0009472" DB="MONDO"/>
              <XRef Type="MIM" ID="243400" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8879662" SubmissionDate="2024-10-02" DateLastUpdated="2024-10-08" DateCreated="2024-03-16" ContributesToAggregateClassification="true">
        <ClinVarSubmissionID localKey="342384|NAT2-related condition"/>
        <ClinVarAccession Accession="SCV004799003" DateUpdated="2024-10-08" DateCreated="2024-03-16" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
          <Comment>This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAT2"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">342384</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000015.2:c.590G&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NAT2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
          <SubmissionName>SUB14767656</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="20908" SubmissionDate="2010-02-16" DateLastUpdated="2013-04-04" DateCreated="2013-04-04" ContributesToAggregateClassification="true">
        <ClinVarSubmissionID localKey="612182.0001_ACETYLATION, SLOW" title="NAT2, ARG197GLN_ACETYLATION, SLOW"/>
        <ClinVarAccession Accession="SCV000020908" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>drug response</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">This mutation, caused by a 590G-A transition in the NAT2 gene that results in an arg197-to-gln (R197Q) substitution, was identified in an individual with slow acetylation (243400) by Vatsis et al. (1991). This allele characterizes the NAT2*6A haplotype (Magalon et al., 2008).</Attribute>
              <Citation>
                <ID Source="PubMed">2068113</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18043717</ID>
              </Citation>
              <XRef DB="OMIM" ID="243400" Type="MIM"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAT2"/>
          </GeneList>
          <Name>NAT2, ARG197GLN</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">ARG197GLN</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612182.0001" Type="Allelic variant"/>
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ACETYLATION, SLOW</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8879662" TraitType="Disease" MappingType="Name" MappingValue="NAT2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NAT2-related disorder"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20908" TraitType="Disease" MappingType="Name" MappingValue="ACETYLATION, SLOW" MappingRef="Preferred">
        <MedGen CUI="C0878587" Name="Slow acetylator due to N-acetyltransferase enzyme variant"/>
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2022-04-15">SCV000494692</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

<VariationArchive VariationID="286" VariationName="NM_000552.5(VWF):c.4820T&gt;A (p.Val1607Asp)" VariationType="single nucleotide variant" Accession="VCV000000286" Version="3" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2025-01-13" DateCreated="2014-02-21" MostRecentSubmission="2024-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15325" VariationID="286">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-"/>
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.4820T&gt;A (p.Val1607Asp)</Name>
      <CanonicalSPDI>NC_000012.12:6018597:A:T</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6018598" stop="6018598" display_start="6018598" display_stop="6018598" variantLength="1" positionVCF="6018598" referenceAlleleVCF="A" alternateAlleleVCF="T"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6127764" stop="6127764" display_start="6127764" display_stop="6127764" variantLength="1" positionVCF="6127764" referenceAlleleVCF="A" alternateAlleleVCF="T"/>
      </Location>
      <ProteinChange>V1607D</ProteinChange>
      <HGVSlist>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="P04275" sequenceAccession="P04275" change="p.Val1607Asp">
            <Expression>P04275:p.Val1607Asp</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6127764A&gt;T" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6127764A&gt;T</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6018598A&gt;T" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6018598A&gt;T</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.111073T&gt;A">
            <Expression>NG_009072.2:g.111073T&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.4820T&gt;A" MANESelect="true">
            <Expression>NM_000552.5:c.4820T&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000543.3" sequenceAccession="NP_000543" sequenceVersion="3" change="p.Val1607Asp">
            <Expression>NP_000543.3:p.Val1607Asp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.111073T&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.4820T&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_587p1" sequenceAccession="LRG_587p1" change="p.Val1607Asp">
            <Expression>LRG_587p1:p.Val1607Asp</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.4" sequenceAccession="NM_000552" sequenceVersion="4" change="c.4820T&gt;A">
            <Expression>NM_000552.4:c.4820T&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114119" DB="ClinGen"/>
        <XRef ID="P04275#VAR_005814" DB="UniProtKB"/>
        <XRef Type="Allelic variant" ID="613160.0003" DB="OMIM"/>
        <XRef Type="rs" ID="61750579" DB="dbSNP"/>
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.4820T&gt;A (p.Val1607Asp) AND Von Willebrand disease type 2A" Accession="RCV000000310" Version="3">
        <ClassifiedConditionList TraitSetID="84">
          <ClassifiedCondition DB="MedGen" ID="C1282968">Von Willebrand disease type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.4820T&gt;A (p.Val1607Asp) AND not provided" Accession="RCV000086803" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-13" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.4820T&gt;A (p.Val1607Asp) AND von Willebrand disease type 2" Accession="RCV002243604" Version="1">
        <ClassifiedConditionList TraitSetID="6722">
          <ClassifiedCondition DB="MedGen" ID="C1264040">von Willebrand disease type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-04-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-13" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2014-02-21" MostRecentSubmission="2024-01-06">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1537829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16322474</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20409624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22431572</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2786201</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8456431</ID>
        </Citation>
        <DescriptionHistory Dated="2024-01-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="84" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9622" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Von Willebrand disease type 2A</ElementValue>
                <XRef ID="MONDO:0015628" DB="MONDO"/>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VWD2A</ElementValue>
                <XRef ID="613554" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17021"/>
                <XRef ID="17021" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal recessive or autosomal dominant</Attribute>
              </AttributeSet>
              <XRef ID="166084" DB="Orphanet"/>
              <XRef ID="C1282968" DB="MedGen"/>
              <XRef ID="MONDO:0015628" DB="MONDO"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RECLASSIFIED - ADRA2C POLYMORPHISM</ElementValue>
                <XRef Type="Allelic variant" ID="104250.0001" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RECLASSIFIED - ADRB1 POLYMORPHISM</ElementValue>
                <XRef Type="Allelic variant" ID="109630.0001" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="6722" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="15807" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE II</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 2</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+2/9461" DB="Genetic Alliance"/>
                <XRef ID="128107007" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE 2A/IIE</ElementValue>
                <XRef Type="Allelic variant" ID="613160.0039" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE 2CB</ElementValue>
                <XRef Type="Allelic variant" ID="613160.0040" DB="OMIM"/>
                <XRef Type="Allelic variant" ID="613160.0042" DB="OMIM"/>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD2</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17020"/>
                <XRef ID="17020" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166081" DB="Orphanet"/>
              <XRef ID="903" DB="Orphanet"/>
              <XRef ID="C1264040" DB="MedGen"/>
              <XRef ID="MONDO:0013304" DB="MONDO"/>
              <XRef Type="MIM" ID="613554" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="210057" SubmissionDate="2012-07-31" DateLastUpdated="2014-02-21" DateCreated="2014-02-21" ContributesToAggregateClassification="false">
        <ClinVarSubmissionID localKey="VWF_4820"/>
        <ClinVarAccession Accession="SCV000119009" DateUpdated="2014-02-21" DateCreated="2014-02-21" Type="SCV" Version="1" SubmitterName="Academic Unit of Haematology, University of Sheffield" OrgID="500250" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.2:c.4820T&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ISTH_VWFDB_2012_1_31</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="20454" SubmissionDate="2018-11-07" DateLastUpdated="2018-11-09" DateCreated="2013-04-04" ContributesToAggregateClassification="false">
        <ClinVarSubmissionID localKey="613160.0003_VON WILLEBRAND DISEASE, TYPE 2A" title="VWF, VAL1607ASP_VON WILLEBRAND DISEASE, TYPE 2A"/>
        <ClinVarAccession Accession="SCV000020454" DateUpdated="2018-11-09" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Goodeve (2010) noted that mutations in the VWF gene, which were sometimes numbered from the transcription start site of the mature protein, are now 'numbered from the first A of the ATG initiator methionine codon (A = +1) at the start of every protein (Met = +1), with cDNA rather than genomic DNA being commonly used as a reference sequence.' Thus, the mutation originally designated VAL844ASP is now designated VAL1607ASP (V1607D).</Attribute>
              <Citation>
                <ID Source="PubMed">20409624</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with von Willebrand disease type 2A (see 613554), characterized by selective loss of high molecular weight VWF multimers, Ginsburg et al. (1989) identified a heterozygous 4820T-A transversion in the VWF gene, resulting in a val844-to-asp (V844D) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">8456431</ID>
              </Citation>
              <XRef DB="OMIM" ID="613554" Type="MIM"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF"/>
          </GeneList>
          <Name>VWF, VAL1607ASP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">VAL1607ASP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613160.0003" Type="Allelic variant"/>
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VON WILLEBRAND DISEASE, TYPE 2A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4925099" SubmissionDate="2022-04-29" DateLastUpdated="2022-05-21" DateCreated="2022-05-21" ContributesToAggregateClassification="false">
        <ClinVarSubmissionID localKey="NM_000552.5:c.4820T&gt;A|OMIM:613554" submittedAssembly="GRCh38"/>
        <ClinVarAccession Accession="SCV002513358" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico" OrgID="507580" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.5:c.4820T&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613554" Type="MIM"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11393183</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7889888" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2024-01-06" ContributesToAggregateClassification="true">
        <ClinVarSubmissionID localKey="S11921|not provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV004221549" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22431572</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20409624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2786201</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16322474</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8456431</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1537829</ID>
          </Citation>
          <Comment>In the published literature, this variant has been reported in individuals with type 2A von Willebrand disease (VWD) (PMIDs: 2786201 (1989), 8456431 (1993), 22431572 (2012)). Experimental studies show this variant severely impairs VWF function (PMIDs: 1537829 (1992), 16322474 (2006), 22431572 (2012)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.4:c.4820T&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20454" TraitType="Disease" MappingType="Name" MappingValue="VON WILLEBRAND DISEASE, TYPE 2A" MappingRef="Preferred">
        <MedGen CUI="C1282968" Name="Von Willebrand disease type 2A"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7889888" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="210057" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4925099" TraitType="Disease" MappingType="XRef" MappingValue="613554" MappingRef="OMIM">
        <MedGen CUI="C1264040" Name="von Willebrand disease type 2"/>
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

</ClinVarVariationRelease>